Jaguar Health (JAGX) to Release Quarterly Earnings on Wednesday

Jaguar Health (NASDAQ:JAGX) will release its earnings data before the market opens on Wednesday, November 13th.

Jaguar Health (NASDAQ:JAGX) last announced its earnings results on Tuesday, August 13th. The biotechnology company reported ($4.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.20) by ($2.84). Jaguar Health had a negative net margin of 350.18% and a negative return on equity of 412.63%. The business had revenue of $2.72 million for the quarter. On average, analysts expect Jaguar Health to post $-1 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Jaguar Health Price Performance

Shares of NASDAQ JAGX opened at $1.02 on Tuesday. Jaguar Health has a fifty-two week low of $0.90 and a fifty-two week high of $30.86. The company has a current ratio of 2.10, a quick ratio of 1.60 and a debt-to-equity ratio of 1.32. The business’s 50 day moving average price is $1.15 and its 200-day moving average price is $3.86.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a research note on Friday, September 13th.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.